This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.
China's customs authorities announced they will strengthen surveillance at ports...
As consumer technology capturing brain data proliferates under the radar of medi...
Drugstores remain an important fixture of the U.S. health-care system that tens ...
As consumer technology capturing brain data proliferates under the radar of medi...
Epic Systems on Friday said its customers will all use a new government-backed n...
CEO Paul Chaplin told CNBC that the expanded approval for 12- to 17-year-olds wo...
Shares of Danish vaccine maker Bavarian Nordic jumped as much as 17% Thursday am...
Eli Lilly may be starting to gain an edge over Novo Nordisk in the GLP-1 market....
Letsile Tebogo of Botswana earned gold while American Kenny Bednarek claimed the...
Novo Nordisk saw price pressure for its GLP-1 drugs Ozempic and Wegovy. Investor...
Novo Nordisk on Wednesday announced its second quarter earnings for 2024.
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 ...
It's about to get a lot easier for patients in the U.S. to access their own medi...
The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs h...
GE Healthcare management continues to execute at a high level on what they can c...
The list of potential health benefits from GLP-1 is only getting longer. Meanwhi...